These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 12375013

  • 1. Interest of investigating p53 status in breast cancer by four different methods.
    Thirion A, Rouanet P, Thezenas S, Detournay D, Grenier J, Lopez-Crapez E.
    Oncol Rep; 2002; 9(6):1167-72. PubMed ID: 12375013
    [Abstract] [Full Text] [Related]

  • 2. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J, Ingram CD.
    Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
    [Abstract] [Full Text] [Related]

  • 3. p53 mutations and histological type of invasive breast carcinoma.
    Marchetti A, Buttitta F, Pellegrini S, Campani D, Diella F, Cecchetti D, Callahan R, Bistocchi M.
    Cancer Res; 1993 Oct 01; 53(19):4665-9. PubMed ID: 8402644
    [Abstract] [Full Text] [Related]

  • 4. The role of p53 mutations in bilateral breast carcinoma.
    Ackerman J, Baunoch DA, Gimotty P, George J, Lane MA, Dawson PJ.
    Mod Pathol; 1995 Apr 01; 8(3):244-8. PubMed ID: 7617647
    [Abstract] [Full Text] [Related]

  • 5. p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques.
    Hurlimann J, Chaubert P, Benhattar J.
    Mod Pathol; 1994 May 01; 7(4):423-8. PubMed ID: 8066070
    [Abstract] [Full Text] [Related]

  • 6. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer.
    Bhargava V, Thor A, Deng G, Ljung BM, Moore DH, Waldman F, Benz C, Goodson W, Mayall B, Chew K.
    Mod Pathol; 1994 Apr 01; 7(3):361-8. PubMed ID: 8058709
    [Abstract] [Full Text] [Related]

  • 7. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer.
    Yamashita H, Nishio M, Toyama T, Sugiura H, Zhang Z, Kobayashi S, Iwase H.
    Breast Cancer Res; 2004 Apr 01; 6(1):R24-30. PubMed ID: 14680497
    [Abstract] [Full Text] [Related]

  • 8. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
    Pollett A, Bedard YC, Li SQ, Rohan T, Kandel R.
    Mod Pathol; 2000 Nov 01; 13(11):1173-9. PubMed ID: 11106073
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time.
    Bukholm IR, Husdal A, Nesland JM, Langerød A, Bukholm G.
    Breast Cancer Res Treat; 2003 Jul 01; 80(2):199-206. PubMed ID: 12908823
    [Abstract] [Full Text] [Related]

  • 10. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M.
    Clin Cancer Res; 2005 Dec 01; 11(23):8348-57. PubMed ID: 16322295
    [Abstract] [Full Text] [Related]

  • 11. Lack of prognostic significance of nm23 expression in human primary breast cancer.
    Göhring UJ, Eustermann I, Becker M, Neuhaus W, Rein DT, Schöndorf T.
    Oncol Rep; 2002 Dec 01; 9(6):1205-8. PubMed ID: 12375020
    [Abstract] [Full Text] [Related]

  • 12. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
    Bánkfalvi A, Tory K, Kemper M, Breukelmann D, Cubick C, Poremba C, Füzesi L, Lellè RJ, Böcker W.
    Pathol Res Pract; 2000 Dec 01; 196(7):489-501. PubMed ID: 10926327
    [Abstract] [Full Text] [Related]

  • 13. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF, Lopes AB, Nonogaki S, Soares FA, Netto MM, Nishimoto IN, Brentani MM.
    Oncol Rep; 2007 Jul 01; 18(1):121-6. PubMed ID: 17549356
    [Abstract] [Full Text] [Related]

  • 14. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, Smith HS.
    Cancer Res; 1994 Jan 15; 54(2):499-505. PubMed ID: 8275488
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
    Zmetakova I, Danihel L, Smolkova B, Mego M, Kajabova V, Krivulcik T, Rusnak I, Rychly B, Danis D, Repiska V, Blasko P, Karaba M, Benca J, Pechan J, Fridrichova I.
    Neoplasma; 2013 Jan 15; 60(6):635-46. PubMed ID: 23906298
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.
    Breast Cancer Res Treat; 2006 Feb 15; 95(3):219-28. PubMed ID: 16244790
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 15; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Jan 15; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 19. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y.
    Clin Cancer Res; 2005 Oct 15; 11(20):7328-33. PubMed ID: 16243804
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer].
    Fan P, Wu Z, Cha X, Wang X, Wang S.
    Zhonghua Wai Ke Za Zhi; 1998 Nov 15; 36(11):655-7. PubMed ID: 11825490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.